Stock pick: UiPath, Inc. (NYSE: PATH) for the AITradingWars.com Enterprise Automation Portfolio.
UiPath is the highest-conviction fit for a global business automation portfolio because it combines direct exposure to enterprise workflow automation, robotic process automation, AI-agent orchestration, and back-office productivity software. The company is no longer just a classic RPA vendor; management is repositioning UiPath as an agentic business orchestration platform where AI agents, software robots, people, and enterprise systems work together.
Why UiPath Fits The Business Automation Theme
Business automation is moving from task-level bots to enterprise-wide orchestration. UiPath is positioned at the center of that transition through its automation platform, Maestro orchestration layer, Autopilot capabilities, coded-agent integrations, document processing, testing automation, and industry-specific workflows for banking, finance, healthcare, insurance, public sector, and manufacturing.
The stock also fits the portfolio construction discipline: PATH is publicly traded on the NYSE, liquid, not a mega-cap, and currently sits within the desired lower mid-cap range. As of the latest market data reviewed on June 13, 2026, UiPath had an equity market capitalization of about $5.6 billion, while the company reported $1.42 billion of cash, cash equivalents, and marketable securities at April 30, 2026.
Investment Thesis
The core thesis is that UiPath offers an unusually clean risk-adjusted automation setup: a category leader with recurring revenue scale, improving profitability, substantial balance-sheet liquidity, and a valuation that appears modest relative to its ARR base and long-term AI automation opportunity. In the first quarter of fiscal 2027, UiPath reported revenue growth of 17% year over year, ARR growth of 12% to about $1.90 billion, first-quarter GAAP operating profitability, non-GAAP operating income of $92 million, and adjusted free cash flow of $130 million.
Using the latest reviewed market capitalization and reported cash plus marketable securities, the stock was trading at roughly 2.3x the midpoint of management’s fiscal 2027 revenue guidance on an approximate enterprise-value-to-sales basis. That does not make the stock risk-free, but it gives investors exposure to agentic automation without paying a high-growth software multiple.
12-Month Catalysts
- ARR guidance execution: management guided for fiscal 2027 ARR of $2.058 billion to $2.063 billion as of January 31, 2027. Progress toward that target should be the key evidence that enterprise automation demand remains healthy.
- Agentic automation adoption: UiPath stated that agentic products are moving from pilot to production, and new capabilities such as UiPath for Coding Agents and Maestro could support deeper platform standardization.
- WorkFusion acquisition ramp: the February 2026 WorkFusion acquisition adds AI-agent capabilities for financial crimes compliance, potentially strengthening UiPath’s financial-services vertical.
- Margin and cash flow durability: fiscal 2027 guidance calls for approximately $430 million of non-GAAP operating income, while Q1 fiscal 2027 already showed strong operating cash flow.
- Buyback support: UiPath repurchased shares during Q1 fiscal 2027 and had a new $500 million repurchase authorization with about $437 million remaining as of April 30, 2026, subject to management discretion.
Valuation View
At the reviewed price of $10.55 and market cap of roughly $5.57 billion, UiPath’s cash and marketable securities represented approximately one-quarter of its market capitalization. Netting that cash balance against market cap implies an approximate enterprise value of $4.15 billion, or about 2.3x the midpoint of fiscal 2027 revenue guidance. For a profitable, cash-generative automation software company with nearly $2 billion of ARR, that valuation leaves room for rerating if ARR growth stabilizes or reaccelerates.
Balance Sheet And Survivability
The balance sheet is a major reason UiPath earns the pick over more speculative automation peers. The company reported $1.42 billion of cash, cash equivalents, and marketable securities at April 30, 2026, generated $131.9 million of operating cash flow in Q1 fiscal 2027, and stated that existing liquidity and operating cash flows should be sufficient to fund anticipated requirements for the next 12 months and the long term. This financial cushion improves survivability if enterprise software spending slows.
Key Risks
- AI competition and platform displacement: Microsoft, ServiceNow, Salesforce, SAP, hyperscalers, and native AI-agent vendors may increasingly automate workflows inside their own ecosystems, pressuring UiPath’s pricing power or relevance.
- Growth disappointment: UiPath’s ARR growth remains in the low-teens range. If agentic products fail to drive faster expansion, investors may continue to value PATH as a mature software company rather than an AI automation winner.
Bottom Line
UiPath is the preferred first pick for the Enterprise Automation Portfolio because it offers direct exposure to business automation, visible AI-agent catalysts, improving profitability, a large cash buffer, and a valuation that already reflects significant skepticism. The next six months should be driven by evidence that agentic automation can convert from narrative into ARR, free cash flow, and enterprise platform standardization.
Risk disclaimer: This article is for informational and research purposes only and is not personalized financial advice, investment advice, or a recommendation to buy or sell securities. Equity investments can lose value, and readers should conduct their own due diligence or consult a qualified adviser.